Free Trial
→ “This Changes Everything” - Trump Hands Millions Massive IRS Gift (From Colonial Metals) (Ad) Free EGRX Stock Alerts

Eagle Pharmaceuticals (EGRX) ESG Score & Sustainability Data

Eagle Pharmaceuticals logo
$0.65 0.00 (0.00%)
(As of 11/20/2024 ET)
Compare

Key ESG Takeaways for Eagle Pharmaceuticals

The key takeaways are AI-generated and highlight the main contributors behind the net impact scores of Eagle Pharmaceuticals. The insights are based on millions of scientific articles, along with the company-specific product and service portfolio.
  • Eagle Pharmaceuticals seems to create the most significant positive value in categories , , and . The largest positive contribution comes from its impact, which is mostly driven by its Bendamustine, Dantrolene, and Pemetrexed products.
  • On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in categories , , and . The negative contribution in the impact category seems to be driven mostly by its Bendamustine, Dantrolene, and Pemetrexed products.
  • To improve its net impact, a company can either grow its positive impacts, or reduce its negative impacts. For example, by doubling its Preclinical research services for physical health business, Eagle Pharmaceuticals would improve its net impact ratio by 2 percentage points.

EGRX Impact Ratio

Net impact ratio represents the net impact of a company. It is defined as the (positive impacts - negative impacts) / positive impacts. The maximum value for net impact ratio is 100%, representing a theoretical company with no negative impacts. The minimum value is -∞. Net scores depend on the value sets that determine the importance of different impact categories.
+54.0%
The default value set, where each category is given the same weight.

Value Sets Value sets can be used to assess how different stakeholder values or emphasis on certain values might affect the net impact ratio.

Millennials
Value set of millennials (b. 1980 - 1999), based on Upright's annual Impact at Work survey.
+59.2%
Most Wanted Workforce
Value set of the most wanted workforce, based on Upright's annual Impact at Work survey.
+39.0%
Society First
Value set that emphasizes society impacts over other impacts.
-41.0%
Knowledge First
Value set that emphasizes knowledge impacts over other impacts.
+62.6%
Health First
Value set that emphasizes health impacts over other impacts.
+76.3%

Eagle Pharmaceuticals ESG Score + Net Impact Profile

ImpactNegativeScorePositive
+0.70
+0.70
+1.64
+1.64
+0.28
+0.28
-0.02
+0.06
+0.08
-0.12
-0.06
+0.06
+0.00
+0.00
+0.89
+0.89
-0.00
+0.00
+0.00
-1.93
-1.93
-1.39
+6.58
+7.98
-0.02
+0.50
+0.52
0.00
+0.00
-0.00
+0.01
+0.01
-0.00
+0.44
+0.45
-1.04
-1.02
+0.02
-0.22
-0.21
+0.01
-0.09
-0.09
+0.00
-0.08
-0.08
+0.00
-0.91
-0.89
+0.01

Upright Model Version 0.4.0
ESG Data Last Updated: April 1, 2022

Ad Priority Gold
JD Vance Predicts: Wall Street vs. Trump & Your Money
Trump's back in the White House, but Wall Street is pissed. Here's the deal: Wall Street's about to purposely crash the bond market to sabotage Trump's comeback.
Get your free guide NOW before it's too late.

About Upright's Net Impact Model

Upright Model

Upright's Net Impact Data quantifies the holistic value creation and impact of companies. It details both the negative and positive impacts a company has on the environment, health of people, society and knowledge, and forms a net sum of these costs and gains based on the economic costs of each impact category. The data is produced by Upright's Net Impact model, which is a mathematical model of the economy that produces continuously updated estimates of the net impact of companies by means of an information integration algorithm. The data is primarily sourced from the CORE open access database, which contains over 200 million scientific papers. Other sources of data include open databases published by the World Bank, IMF, WHO, OECD, IPCC, CDC and USDA.

Eagle Pharmaceuticals ESG Score - Frequently Asked Questions

How is Eagle Pharmaceuticals doing in terms of sustainability?

According to The Upright Project, which measures holistic value creation and impact of companies, Eagle Pharmaceuticals has a net impact ratio of 54.0%, indicating an overall positive sustainability impact. Eagle Pharmaceuticals seems to create the most significant positive value in the categories of Physical diseases, Taxes, and Creating knowledge. On the other hand, these positive outcomes are achieved by using resources or causing negative impacts in the categories of Scarce human capital, Physical diseases, and GHG emissions. Learn more on the sustainability of Eagle Pharmaceuticals.


More ESG Stocks and Research Tools

Related Companies
Stock Lists
Sustainability Tools

This page (NASDAQ:EGRX) was last updated on 11/21/2024 by MarketBeat.com Staff
From Our Partners
The Crypto That’s Making Wall Street Sweat
The Crypto Wall Street Is Desperate to Hide It's happening now, right under everyone's radar. Big tech gian...
Crypto 101 Media | Sponsored
Missed Nvidia? Watch this ASAP
This little-known project that Bill Gates has been quietly working on that’s about to unleash an AI breakthrou...
Brownstone Research | Sponsored
Musk’s new company could top a trillion?
The investment legend who predicted the rise of Bitcoin, Facebook and streaming services like Netflix… Just...
Paradigm Press | Sponsored
24/7 Automated Profits in Crypto
What if you could make consistent daily profits in crypto with minimal effort? Beyond trading lies a vast w...
Crypto Swap Profits | Sponsored
The pin that pops the AI bubble
My new documentary explores the background to this pattern and how and why I believe it will almost certainly ...
Porter & Company | Sponsored
Crypto’s next big bull run?
Juan Villaverde may be America’s top crypto expert. And he says something big is coming for crypto – on Nov...
Weiss Ratings | Sponsored
“This Changes Everything” - Trump Hands Millions Massive IRS Gift
Now it's your time to return the favor by taking advantage of this tax "revenge loophole." Because even as ...
Colonial Metals | Sponsored
Tim Sykes’ Urgent Trade Alert: “Make this move now”
WARNING: 80 Wall Street banks are gearing up for MASSIVE D.C. shock This $2 trillion D.C. shock is NOT abou...
Timothy Sykes | Sponsored